Mydecine to Present at the KCSA Psychedelics Virtual Investor Conference on October 14th
/PRNewswire/ -- Mydecine Innovations Group (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) ("Mydecine" or the "Company'), a biopharmaceutical company focused on the...
Stay updated with breaking news from Josh Bartch. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- Mydecine Innovations Group (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) ("Mydecine" or the "Company'), a biopharmaceutical company focused on the...
A glance at some of the day's highlights from the Proactive Investors US and Canada newswires
A glance at some of the day's highlights from the Proactive Investors US and Canada newswires
Mydecine Innovations Group Inc. (NEO:MYCO) (OTCMKTS:MYCOF) (FRA:0NFA) CEO Josh Bartch tells Proactive its R&D team has made groundbreaking advances...
A glance at some of the day's highlights from the Proactive Investors US and Canada newswires